Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.5K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.4K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

870
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
870
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

707
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study.

Frontiers in medicine·2026
Same author

Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis.

Transplantation and cellular therapy·2026
Same author

Real-World Treatment Patterns and Safety Outcomes of Targeted Therapies in a Single-Center Chronic Lymphocytic Leukemia Cohort.

Medicina (Kaunas, Lithuania)·2026
Same author

HIV-associated lymphoproliferative disorders: Single-center experience.

Medicine·2026
Same author

Potentially Inappropriate Prescription and Its Association with Index Hospitalization: A Multicenter, Cross-Sectional Study Using TIME Criteria.

Drugs & aging·2026
Same author

Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts.

Journal of hepatology·2026

Related Experiment Video

Updated: Apr 1, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.6K

Miliary Tuberculosis Induced Acute Liver Failure.

Tayfur Toptas1, Birkan Ilhan2, Huseyin Bilgin3

  • 1Department of Hematology, Van Training and Research Hospital, 65300 Van, Turkey.

Case Reports in Infectious Diseases
|October 6, 2015
PubMed
Summary
This summary is machine-generated.

Hepatobiliary tuberculosis, though rare, can cause acute liver failure (ALF). Early antituberculosis treatment is critical for survival, even in severe cases, as demonstrated by a successful patient outcome.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K

Related Experiment Videos

Last Updated: Apr 1, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.6K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Pulmonology

Background:

  • Hepatobiliary tuberculosis is a rare condition, particularly in non-endemic regions.
  • It carries a high mortality rate and is often diagnosed late in the disease progression.
  • Acute liver failure (ALF) due to tuberculosis is exceptionally uncommon, with prior cases diagnosed posthumously.

Purpose of the Study:

  • To report a case of acute liver failure as the initial presentation of miliary tuberculosis.
  • To emphasize the critical importance of timely antituberculosis treatment in suspected cases.
  • To highlight the potential for successful treatment of this severe presentation.

Main Methods:

  • Clinical and radiological examination to identify suggestive findings of tuberculosis.
  • Exclusion of other potential causes of acute liver failure.
  • Initiation of immediate antituberculosis treatment, carefully managing drug use in the context of ALF.

Main Results:

  • A case of miliary tuberculosis presenting as acute liver failure was successfully diagnosed and treated.
  • The patient responded positively to antituberculosis therapy.
  • Avoidance of hepatotoxic drugs was crucial for safe management.

Conclusions:

  • Acute liver failure can be a presenting manifestation of miliary tuberculosis.
  • Prompt initiation of antituberculosis treatment is vital for improving outcomes in these critical cases.
  • Hepatobiliary tuberculosis presenting as ALF is treatable with appropriate management, even in complex scenarios.